Summary: We have reported a successful case of curative partial liver resection of metachronous liver metastasis from advanced gastric cancer. The patient was 56 years old and has undergone total gastrectomy with D2 lymph node dissection (2 type, well-differentiated adenocarcinoma, HoPonose, Stage 2). At 18 months later, follow-up ultrasound detected liver metastasis in the right posterior segment. Together with other imaging modalities, it was diagnosed as a solitary lesion without any other recurrence, and we performed partial resection of the right posterior segment. During the operation, there was no sign of any other recurrence (no peritoneal dissemination, no lymph node metastasis, and no other liver metastasis). Two Mitomycin-C (MMC) intravenous injections were given as postoperative chemotherapy. Usually, surgery for liver metastasis from gastric cancer is very rare as a curative therapy, because it is difficult to predict the effectiveness of the operation. In the present case, we decided on the operation since there was no sign of any other recurrence. It has now been 13 years to date since the partial liver resection and the patient remains free from recurrence.
had no subjective symptoms and his general condition was stable. Also on physical examination there was no abnormal sign at all. On blood biochemical examination, the liver function was normal, and tumor markers (carcinoembryonic antigen: CEA, afetoprotein: AFP, carbo-hydrate antigen 19-9: CA 19-9) were all within normal ranges. After admission, an abdominal computed tomographic scan examination (CT scan) and angiography were performed to help to determine the malignancy of the liver tumor. The CT scan detected a tumor mass lesion about 2 cm in diameter at the edge of the right posterior segment (Fig. 3) . The mass lesion was enhanced and therefore considered to be malignant. Angiography showed a hyper vascular area in the same position also indicating malignancy. According to the results of these radiography examinations, it was diagnosed as metachronous hepatic metastasis from the gastric cancer. The hepatic lesion was solitary, and there was no sign of recurrence in the abdominal lymph nodes or of the peritoneal dissemination. The general condition of the patient was sufficiently stable to undergo surgical treatment for this hepatic metastasis. Therefore a partial resection of the liver was indicated as a curative operation for the metastatic lesion.
In May 1988, he underwent the partial resection of the right posterior segment. During the operation, it was confirmed that there were no ascites pooling, no lymph node metastasis, and no peritoneal dissemination in the abdominal cavity, which indicated no other recurrence. Intra operative ultrasonography found no other metastatic lesion in the liver. The hepatic lesion appeared to be superficial on the surface of the liver. A microscopic analysis of the resected liver segment revealed that cancer cells proliferated expansively and formed a mass lesion with some part protruding above the surface of the liver (Fig. 4) . In demarcation between the tumor mass lesion and normal liver tissue, there was notable infiltration of phlogocyte mainly composed of lymphocyte. Physiological and histological findings of the dissected liver tumor showed a well-differentiated adenocarcinoma, of the same histology as the primary gastric cancer. On the day of the operation and on the next day, mitomycin-C (MMC) was injected intravenously, 20 mg and 10 mg, respectively. With a stable postoperative course, the patient was discharged on the 22nd postoperative day. He is alive and well to date at more than 10 years since the partial resection of the liver with no sign of recurrence.
DISCUSSION
Among synchronous or metachronous liver metastasis from gastric cancer, several reports have demonstrated the high incidence of papillary and of well-differentiated tubular adenocarcinoma. And macroscopically, there is a high incidence of macroscopic type 2 (ulcerated carcinoma with sharply demarcated and raised margins), and of type 1 (polypoid tumors, sharply demarcated from the surrounding mucosa, usually attached on a wide base). In synchronous or metachronous liver metastasis the prognosis is very poor, regardless of the kind of therapy, and the majority of patients are treated with nonsurgical methods.
The resection rate of synchronous liver metastasis has been between 3.4 and 20.0% with a subsequent median survival of 9 to 26.5 months 111 ,2]. In synchronous liver metastasis, it is very difficult to determine its resectability owing to the high inci- 
